GSK
Price
$42.86
Change
-$0.13 (-0.30%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
JNJ
Price
$158.17
Change
+$0.16 (+0.10%)
Updated
Mar 28, 6:59 PM EST
18 days until earnings call
Ad is loading...

Compare trend and price GSK vs JNJ

Header iconGSK vs JNJ Comparison
Open Charts GSK vs JNJBanner chart's image
GSK
Price$42.86
Change-$0.13 (-0.30%)
Volume$726K
CapitalizationN/A
Johnson & Johnson
Price$158.17
Change+$0.16 (+0.10%)
Volume$1.31M
CapitalizationN/A
View a ticker or compare two or three
GSK vs JNJ Comparison Chart

Loading...

GSKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JNJDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GSK vs. JNJ commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a StrongBuy and JNJ is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (GSK: $42.87 vs. JNJ: $158.19)
Brand notoriety: GSK: Not notable vs. JNJ: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GSK: 52% vs. JNJ: 83%
Market capitalization -- GSK: $87.98B vs. JNJ: $381.2B
GSK [@Pharmaceuticals: Major] is valued at $87.98B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $381.2B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 2 FA rating(s) are green whileJNJ’s FA Score has 4 green FA rating(s).

  • GSK’s FA Score: 2 green, 3 red.
  • JNJ’s FA Score: 4 green, 1 red.
According to our system of comparison, JNJ is a better buy in the long-term than GSK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 3 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).

  • GSK’s TA Score: 3 bullish, 5 bearish.
  • JNJ’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than GSK.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а +1.18% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.67%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was -2.01%.

Reported Earning Dates

GSK is expected to report earnings on May 01, 2024.

JNJ is expected to report earnings on Apr 16, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for GSK with price predictions.
OPEN
A.I.dvisor published
a Summary for JNJ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JNJ($381B) has a higher market cap than GSK($88B). JNJ has higher P/E ratio than GSK: JNJ (30.42) vs GSK (14.16). GSK YTD gains are higher at: 16.808 vs. JNJ (1.691). JNJ has higher annual earnings (EBITDA): 23.3B vs. GSK (9.08B). JNJ has more cash in the bank: 22.9B vs. GSK (4.99B). GSK has less debt than JNJ: GSK (18B) vs JNJ (29.3B). JNJ has higher revenues than GSK: JNJ (85.2B) vs GSK (30.3B).
GSKJNJGSK / JNJ
Capitalization88B381B23%
EBITDA9.08B23.3B39%
Gain YTD16.8081.691994%
P/E Ratio14.1630.4247%
Revenue30.3B85.2B36%
Total Cash4.99B22.9B22%
Total Debt18B29.3B61%
FUNDAMENTALS RATINGS
GSK vs JNJ: Fundamental Ratings
GSK
JNJ
OUTLOOK RATING
1..100
6855
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
5230
SMR RATING
1..100
2320
PRICE GROWTH RATING
1..100
4656
P/E GROWTH RATING
1..100
5633
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GSK's Valuation (10) in the Pharmaceuticals Major industry is in the same range as JNJ (12). This means that GSK’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (30) in the Pharmaceuticals Major industry is in the same range as GSK (52). This means that JNJ’s stock grew similarly to GSK’s over the last 12 months.

JNJ's SMR Rating (20) in the Pharmaceuticals Major industry is in the same range as GSK (23). This means that JNJ’s stock grew similarly to GSK’s over the last 12 months.

GSK's Price Growth Rating (46) in the Pharmaceuticals Major industry is in the same range as JNJ (56). This means that GSK’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's P/E Growth Rating (33) in the Pharmaceuticals Major industry is in the same range as GSK (56). This means that JNJ’s stock grew similarly to GSK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GSKJNJ
RSI
ODDS (%)
Bearish Trend 1 day ago
37%
Bearish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
51%
Momentum
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
41%
MACD
ODDS (%)
Bearish Trend 1 day ago
37%
Bearish Trend 1 day ago
36%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
48%
Bearish Trend 1 day ago
40%
Advances
ODDS (%)
Bullish Trend 16 days ago
49%
Bullish Trend 1 day ago
43%
Declines
ODDS (%)
Bearish Trend 11 days ago
48%
Bearish Trend 4 days ago
43%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
42%
Bullish Trend 1 day ago
64%
Aroon
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
38%
View a ticker or compare two or three
Ad is loading...
GSKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JNJDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UMH16.240.40
+2.53%
UMH Properties
CNXC66.190.99
+1.52%
Concentrix Corp
SBT5.170.07
+1.37%
Sterling Bancorp
SWAG1.460.01
+0.89%
Stran & Company
TTD87.400.19
+0.22%
Trade Desk (The)

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with SNY. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
-0.28%
SNY - GSK
55%
Loosely correlated
-1.92%
MRK - GSK
39%
Loosely correlated
+0.15%
NVS - GSK
39%
Loosely correlated
+0.89%
AZN - GSK
34%
Loosely correlated
-0.79%
JNJ - GSK
33%
Loosely correlated
+0.15%
More